Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings (Accumulated Deficit)
Beginning balance (in shares) at Dec. 31, 2020		73,314,026
Beginning balance at Dec. 31, 2020	$ 300,252	$ 7	$ 369,467	$ (69,222)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		4,941,362
Issuance of common stock upon exercise of stock options	9,773		9,773
Issuance of common stock upon settlement of restricted stock units (in shares)		19,017
Exercise of common stock warrants (in shares)		72,407
Stock-based compensation expense	52,245		52,245
Shares withheld related to net share settlement of restricted stock units (in shares)		(1,730)
Shares withheld related to net share settlement of restricted stock units	(236)		(236)
Issuance of common stock in connection with an acquisition (in shares)		650,740
Issuance of common stock in connection with acquisition	71,003		71,003
Issuance of common stock in connection with follow-on offering, net of underwriting discounts, commissions, and offering costs (in shares)		2,300,000
Issuance of common stock in connection with follow-on offering, net of underwriting discounts, commissions, and offering costs	263,931	$ 1	263,930
Issuance of common stock under employee stock purchase plan (in shares)		243,725
Issuance of common stock under employee stock purchase plan	4,145		4,145
Purchase of capped calls	(58,523)		(58,523)
Net income (loss)	76,499			76,499
Ending balance (in shares) at Sep. 30, 2021		81,539,547
Ending balance at Sep. 30, 2021	719,089	$ 8	711,804	7,277
Beginning balance (in shares) at Jun. 30, 2021		77,626,866
Beginning balance at Jun. 30, 2021	716,096	$ 8	737,924	(21,836)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		3,656,385
Issuance of common stock upon exercise of stock options	6,841		6,841
Issuance of common stock upon settlement of restricted stock units (in shares)		12,571
Stock-based compensation expense	21,417		21,417
Issuance of common stock under employee stock purchase plan (in shares)		243,725
Issuance of common stock under employee stock purchase plan	4,145		4,145
Purchase of capped calls	(58,523)		(58,523)
Net income (loss)	29,113			29,113
Ending balance (in shares) at Sep. 30, 2021		81,539,547
Ending balance at Sep. 30, 2021	$ 719,089	$ 8	711,804	7,277
Beginning balance (in shares) at Dec. 31, 2021	83,659,665	83,659,665
Beginning balance at Dec. 31, 2021	$ 807,078	$ 8	740,849	66,221
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	2,074,763	2,074,763
Issuance of common stock upon exercise of stock options	$ 10,726	$ 1	10,725
Issuance of common stock upon settlement of restricted stock units (in shares)		179,559
Issuance of common stock upon settlement of restricted stock units	(8)		(8)
Stock-based compensation expense	96,582		96,582
Shares withheld related to net share settlement of restricted stock units (in shares)		(188,726)
Issuance of common stock under employee stock purchase plan (in shares)		162,796
Issuance of common stock under employee stock purchase plan	7,662		7,662
Stock repurchased during period (in shares)		(4,434,331)
Repurchases of stock	(150,070)	$ (1)	(150,069)
Net income (loss)	$ (53,402)			(53,402)
Ending balance (in shares) at Sep. 30, 2022	81,831,178	81,831,178
Ending balance at Sep. 30, 2022	$ 718,568	$ 8	705,741	12,819
Beginning balance (in shares) at Jun. 30, 2022		82,188,372
Beginning balance at Jun. 30, 2022	757,071	$ 8	688,021	69,042
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		270,390
Issuance of common stock upon exercise of stock options	1,319		1,319
Issuance of common stock upon settlement of restricted stock units (in shares)		(319)
Issuance of common stock upon settlement of restricted stock units	(8)		(8)
Stock-based compensation expense	38,206		38,206
Shares withheld related to net share settlement of restricted stock units (in shares)		(188,726)
Issuance of common stock under employee stock purchase plan (in shares)		114,902
Issuance of common stock under employee stock purchase plan	3,231		3,231
Stock repurchased during period (in shares)		(930,893)
Repurchases of stock	(25,028)		(25,028)
Net income (loss)	$ (56,223)			(56,223)
Ending balance (in shares) at Sep. 30, 2022	81,831,178	81,831,178
Ending balance at Sep. 30, 2022	$ 718,568	$ 8	$ 705,741	$ 12,819